Clinical Trials on Locally Advanced Resectable Esophageal Squamous Cell Carcinoma in Brazil
Total 104 results
-
Barretos Cancer HospitalRecruitingLocally Advanced Malignant NeoplasmBrazil
-
Tiago BiachiUnknownEsophageal Squamous Cell CarcinomaBrazil
-
Instituto do Cancer do Estado de São PauloUnknownAdvanced Cutaneous Squamous Cell CarcinomaBrazil
-
Hoffmann-La RocheActive, not recruitingAdvanced or Metastatic Esophageal Squamous Cell CarcinomaKorea, Republic of, Argentina, Denmark, France, Spain, Brazil, United Kingdom, Turkey, Czechia, Thailand, Russian Federation, Italy, Poland, Taiwan, Singapore, Ukraine, Kenya, Hungary
-
AstraZenecaRecruitingLocally Advanced Head and Neck Squamous Cell CarcinomaUnited States, Spain, Italy, Canada, Korea, Republic of, United Kingdom, Germany, Vietnam, Japan, France, India, Taiwan, Thailand, Malaysia, Turkey, Brazil, Belgium, Poland, Austria, Hungary
-
Hoffmann-La RocheTerminatedLocally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)United States, Korea, Republic of, Canada, Australia, Russian Federation, United Kingdom, Belgium, Brazil, China, France, Italy, Portugal, Spain, Japan, India, Thailand, Ukraine, Taiwan, Poland, Turkey, Hungary, South Africa, Germany
-
Merck Sharp & Dohme LLCActive, not recruitingEsophageal Squamous Cell Carcinoma (ESCC)Japan, Italy, Brazil, Chile, France, Germany, Korea, Republic of, Norway, Singapore, Switzerland, Taiwan, Thailand, Turkey
-
AmgenNo longer availableNon Small-cell Lung Cancer | Locally Advanced Unresectable NSCLC | Locally Advanced Metastatic NSCLCUnited States, Taiwan, Israel, Saudi Arabia, Brazil, Argentina
-
Merck Sharp & Dohme LLCActive, not recruitingEsophageal Squamous Cell Carcinoma (ESCC) | Gastroesophageal Junction Carcinoma (GEJC) | Esophageal Adenocarcinoma (EAC)China, Canada, United States, Argentina, Belgium, Brazil, Chile, Czechia, Denmark, Estonia, France, Germany, Guatemala, Hong Kong, Hungary, Italy, Japan, Korea, Republic of, Mexico, Peru, Philippines, Portugal, Romania, Russian Federation and more
-
AstraZenecaActive, not recruitingEsophageal Squamous Cell CarcinomaBelgium, France, Spain, United States, Thailand, Vietnam, Brazil, Japan, Mexico, Russian Federation, Turkey, China, Taiwan, Canada, Korea, Republic of, Poland
-
Instituto do Cancer do Estado de São PauloInstituto de Ciências Biomédicas da Universidade de São PauloNot yet recruitingOral Squamous Cell Carcinoma (OSCC)Brazil
-
Instituto do Cancer do Estado de São PauloWithdrawnHead and Neck Squamous Cell CarcinomaBrazil
-
Barretos Cancer HospitalCompletedHead and Neck Squamous Cell CarcinomaBrazil
-
UPECLIN HC FM Botucatu UnespCompleted
-
Regeneron PharmaceuticalsCompletedAdvanced Cutaneous Squamous Cell CarcinomaUnited States, Spain, France, Italy, Australia, Germany, Brazil, Greece
-
Merck Sharp & Dohme LLCRecruitingEsophageal Squamous Cell CarcinomaJapan, Korea, Republic of, Taiwan, China, Norway, Italy, Switzerland, Brazil, Germany, Singapore, Turkey, Thailand, Chile
-
Instituto do Cancer do Estado de São PauloCompleted
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedUnresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal JunctionUnited States, Spain, Italy, Australia, Russian Federation, Taiwan, Korea, Republic of, Thailand, Canada, Turkey, Germany, Romania, United Kingdom, Hungary, Brazil, France, Japan
-
Lucas Vieira dos SantosFundação de Amparo à Pesquisa do Estado de São Paulo; University of Campinas...TerminatedHead and Neck Neoplasms | Squamous Cell CarcinomaBrazil
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Spain, Taiwan, United Kingdom
-
Instituto Nacional de Cancer, BrazilCompletedSquamous Cell Carcinoma of Hypopharynx | Squamous Cell Carcinoma of Oropharynx | Squamous Cell Carcinoma of NasopharynxBrazil
-
Hoffmann-La RocheRecruitingMetastatic Melanoma | Non-small Cell Lung Cancer | Solid Tumors | Esophageal Squamous Cell CarcinomaUnited States, Denmark, Israel, Portugal, Singapore, Spain, United Kingdom, Mexico, Korea, Republic of, Brazil, Turkey, Moldova, Republic of, Georgia
-
Instituto do Cancer do Estado de São PauloUniversity of Sao PauloCompletedHead and Neck Cancer | Oropharyngeal Cancer | Oral Cavity CancerBrazil
-
Baylor College of MedicineM.D. Anderson Cancer Center; William Marsh Rice University; Instituto do Cancer... and other collaboratorsNot yet recruitingSuspected or Known Squamous Cell Neoplasia | Prior History of Squamous Cell Dysplasia and /or NeoplasiaBrazil, United States
-
BioNTech SERecruitingRecurrent Head and Neck Cancer | Unresectable Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck CancerGermany, United States, France, United Kingdom, Korea, Republic of, Spain, Poland, Belgium, Brazil, Taiwan, Italy, Canada, Czechia, Australia, Turkey, Mexico, Chile, Argentina, Austria, Hungary, Portugal, Sweden
-
Brooklyn ImmunoTherapeutics, LLCCompletedSquamous Cell Carcinoma of the Oral CavityUnited States, Brazil, United Kingdom, Canada
-
SanofiCompletedHead and Neck Neoplasms | Neoplasm Metastasis | Neoplasm Recurrence, LocalRussian Federation, United States, Canada, Germany, Hungary, Italy, South Africa, Argentina, Uruguay, Austria, Switzerland, Israel, Belgium, France, Australia, Brazil, Greece, Guadeloupe, Réunion, Spain
-
ISA PharmaceuticalsRegeneron PharmaceuticalsActive, not recruitingSquamous Cell Carcinoma of the Oropharynx | HPV16 PositiveNetherlands, United States, United Kingdom, France, Belgium, Czechia, Spain, Italy, Germany, Brazil, Hungary, Mexico, Poland
-
Incyte CorporationRecruitingCutaneous Squamous Cell CarcinomaKorea, Republic of, Spain, France, Turkey, Brazil, Chile, Australia, Romania, South Africa, New Zealand, Croatia, Netherlands, Canada, North Macedonia, Hungary
-
Regeneron PharmaceuticalsSanofiRecruitingCutaneous Squamous Cell CarcinomaUnited States, Australia, Spain, Germany, Belgium, Italy, France, Japan, United Kingdom, Brazil, Canada, Greece, Ireland, New Zealand, Poland, Russian Federation
-
Merck Sharp & Dohme LLCCompletedHead and Neck Squamous Cell Carcinoma (HNSCC)United States, Australia, Austria, Brazil, France, Israel, Korea, Republic of, Norway, Spain, United Kingdom
-
AstraZenecaActive, not recruitingMetastatic Urothelial Cancer | Unresectable Locally Advanced Urothelial CancerUnited States, Italy, Spain, Canada, Hungary, Poland, Argentina, Thailand, Vietnam, Turkey, Korea, Republic of, Brazil, Czechia, India, Japan, Philippines, Russian Federation, China, Taiwan, Israel, Australia, Bulgaria
-
AstraZenecaCompletedSquamous Cell Carcinoma of the Head and NeckCroatia, Sweden, United States, Czech Republic, Italy, Russian Federation, South Africa, Spain, United Kingdom, Estonia, Latvia, Lithuania, Norway, Canada, Netherlands, Argentina, Belgium, Greece, Thailand, India, Israel, Malaysia, ... and more
-
Merck Sharp & Dohme LLCActive, not recruitingSquamous Cell Carcinoma of Head and NeckCanada, United States, Argentina, Australia, Brazil
-
Weill Medical College of Cornell UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; University of Sao Paulo and other collaboratorsActive, not recruitingHPV Infection | HIV-1-infection | HPV Positive Oropharyngeal Squamous Cell CarcinomaBrazil, Mexico, Puerto Rico
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; GORTEC (Head and Neck Oncology and Radiotherapy...Active, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States, Spain, Korea, Republic of, Taiwan, China, Argentina, France, Japan, Israel, United Kingdom, Belgium, Germany, Portugal, Greece, Italy, Georgia, Australia, Czechia, Brazil, Canada, Austria, Russian Federation, Switzerland and more
-
GlaxoSmithKlineMerck Sharp & Dohme LLCTerminatedNeoplasms, Head and NeckUnited States, Argentina, Italy, Spain, Belgium, Denmark, Poland, Canada, Germany, Korea, Republic of, Ireland, Japan, United Kingdom, Romania, Hungary, Australia, France, Brazil, Sweden, Russian Federation
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedSquamous Cell Carcinoma of the Head and NeckBrazil, Italy, United Kingdom, United States, Hong Kong, France, Netherlands, Germany, Argentina, Canada, Japan, Korea, Republic of, Spain, Switzerland, Taiwan
-
Merck Sharp & Dohme LLCActive, not recruitingHead and Neck NeoplasmsUnited States, Australia, Austria, Belgium, Brazil, Canada, Colombia, Czechia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Poland, Spain, Taiwan, Turkey, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingHead and Neck NeoplasmsPoland, Canada, Brazil, Belgium, Japan, United States, Argentina, Australia, Austria, Chile, Colombia, France, Germany, Hungary, Ireland, Israel, Korea, Republic of, Portugal, Russian Federation, Spain, Switzerland, Taiwan, Ukraine, United...
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingHead and Neck Squamous Cell CarcinomaUnited States, Australia, Brazil, Canada, China, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
GlaxoSmithKlineRecruitingNeoplasms, Head and NeckUnited States, Italy, Japan, Norway, Spain, Taiwan, Australia, United Kingdom, Belgium, Brazil, Germany, Greece, Romania, Sweden, Turkey, Canada, Korea, Republic of, China, France, Argentina, India, Poland, Israel, Portugal, Mexico, Czechia, Hunga...
-
Latin American Cooperative Oncology GroupRecruitingHIV Infections | Anal Squamous Cell CarcinomaBrazil
-
GlaxoSmithKlineiTeos TherapeuticsRecruitingNeoplasms, Head and NeckUnited States, Italy, Spain, Taiwan, Germany, Greece, Korea, Republic of, Romania, Sweden, Turkey, Canada, Argentina, Finland, Brazil, Japan, Poland, Portugal, France, Denmark, Hungary, Norway
-
Bristol-Myers SquibbCompletedHead and Neck CancerUnited States, Brazil, Italy, South Africa, Spain, Canada, Argentina, Belgium, Chile, Czechia, Finland, France, Ireland, Mexico, Netherlands, Norway, Romania, Russian Federation, Sweden, Turkey, United Kingdom
-
GlaxoSmithKlineMerck Sharp & Dohme LLCTerminatedNeoplasms, Head and NeckUnited States, Argentina, Australia, Spain, Taiwan, Germany, Israel, Poland, Canada, Japan, Portugal, Ireland, Netherlands, China, Brazil, France, Korea, Republic of, Italy, Romania, Russian Federation, United Kingdom, Norway, Switz... and more
-
Merck Sharp & Dohme LLCEisai Inc.RecruitingSquamous Cell Carcinoma of Head and NeckUnited States, Australia, Canada, Denmark, France, Israel, Korea, Republic of, Norway, Portugal, Romania, Spain, Taiwan, United Kingdom, Colombia, Brazil
-
AstraZenecaCompletedRecurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHNUnited States, France, Italy, Spain, Belgium, Czechia, Romania, Taiwan, Korea, Republic of, Brazil, Hungary, Japan, Russian Federation, Australia, Germany, Israel, Serbia, Bulgaria, Ukraine, Argentina, Poland, Chile, Croatia, Georgia
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedHead and Neck CancerItaly, United States, Israel, Japan, Australia, Austria, Brazil, France, Germany, Greece, Ireland, Korea, Republic of, Mexico, Poland, Spain, Switzerland, Taiwan, United Kingdom
-
AstraZenecaInnate PharmaActive, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States, France, Italy, Spain, Belgium, Canada, Taiwan, Switzerland, Korea, Republic of, Japan, Poland, Russian Federation, United Kingdom, Austria, Brazil, Germany, Netherlands, Portugal, Australia, Philippines, Bulgaria, G... and more